Last reviewed · How we verify
Heparin Infusion
Heparin Infusion is a Small molecule drug developed by Columbia University. It is currently FDA-approved. Also known as: Heparin, new regimen.
At a glance
| Generic name | Heparin Infusion |
|---|---|
| Also known as | Heparin, new regimen |
| Sponsor | Columbia University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery (PHASE1)
- Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients
- Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis (PHASE3)
- The Effect of Music on Anxiety Levels and Sleep Quality in Patients Who Have a Myocardial Infarction (NA)
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma (PHASE2)
- A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants (PHASE1)
- A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant (PHASE2)
- A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Heparin Infusion CI brief — competitive landscape report
- Heparin Infusion updates RSS · CI watch RSS
- Columbia University portfolio CI
Frequently asked questions about Heparin Infusion
What is Heparin Infusion?
Heparin Infusion is a Small molecule drug developed by Columbia University.
Who makes Heparin Infusion?
Heparin Infusion is developed and marketed by Columbia University (see full Columbia University pipeline at /company/columbia-university).
Is Heparin Infusion also known as anything else?
Heparin Infusion is also known as Heparin, new regimen.
What development phase is Heparin Infusion in?
Heparin Infusion is FDA-approved (marketed).
Related
- Manufacturer: Columbia University — full pipeline
- Also known as: Heparin, new regimen
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing